Lenco Diagnostic Laboratories (Lenco), one of NYC's largest privately-owned full service reference laboratories, provides an update on COVID-19 testing and recently launched IgG and IgM serology testing to detect antibodies against COVID-19.
In mid-March, Lenco became one of the first 28 approved New York laboratories to start testing for COVID-19 with a molecular based assay utilizing PCR technology for the qualitative detection of nucleic acid in respiratory specimens in patients who meet the Centers for Disease Control and Prevention criteria.
October marks the beginning of flu season. As in previous years, flu cases are expected to peak between December and February, and taper off around May. While most cases of the “flu” are diagnosed and treated empirically, based on the common symptoms with which it usually presents (fever, headache, sore throat, cough, runny nose, as well as body aches being the most common ones), this is obviously not a 100% accurate method of diagnosis. Instead, physicians should consider using molecular influenza assays to get an accurate diagnosis, especially in the case of patients with complications.